Top Markets
#1 Black Phoenix Black Phoenix +167.48%
#2 Islamic Coin Islamic Coin +158.25%
#3 Glidr Glidr +84.34%
#4 Acurast Acurast +43.60%
#5 Cryptopia Cryptopia +20.92%
#6 Quantum Resistant Ledger Quantum Resistant Ledger +18.51%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.45%
#8 Test Test +17.66%
#9 Victoria VR Victoria VR +12.65%
#10 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +10.37%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Panacos Pharmaceuticals, Inc. Panacos Pharmaceuticals, Inc.

Panacos Pharmaceuticals, Inc.

PANC
Rank in Stocks #42054
Panacos Pharmaceuticals, Inc. functions as an early-stage biotechnology firm... Panacos Pharmaceuticals, Inc. functions as an early-stage biotechnology firm specializing in the research and development of orally administered small-molecule therapeutics. These innovative drugs are crafted to combat human immunodeficiency virus (HIV) and various other viral diseases affecting humans. The company's scientific methodology concentrates on identifying novel targets within the viral life cycle, specifically focusing on processes like virus maturation and fusion. Currently, their product portfolio includes advanced initiatives, such as second- and third-generation programs, centered on inhibiting HIV maturation. Founded in 1999, the company's main operations are situated in Watertown, Massachusetts.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$5.37K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Panacos Pharmaceuticals, Inc. (PANC)

Category

Healthcare
Stock price history for Panacos Pharmaceuticals, Inc. (PANC)
Highest end of day price: $0.00 on 2026-08-01

Lowest end of day price: $0.40 on 2005-03-01
Stock price history of Panacos Pharmaceuticals, Inc. from 2005 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 0.00%
2025 -4.50%
2024 9,900.00%
2023 0.00%
2022 -90.00%
2021 -99.30%
2020 15,555.94%
2019 389.88%
2018 -6.29%
2017 143.90%
2016 -33.62%
2015 23.53%
2014 -99.79%
2013 -38.47%
2012 117.54%
2011 -41.33%
2010 -73.55%
2009 -84.59%
2008 -87.50%
2007 -78.30%
2006 -27.11%
2005 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 33.33%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 35.10%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 7.69%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $263.09 18.09%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.98%
KR